Minerva Neurosciences

(NASDAQ) NERV

Current Price$4.68

Market Cap$208.25M

Since IPO (2014)-91%

5 Year-76%

1 Year+163%

1 Month-11%

Minerva Neurosciences Financials at a Glance

Market Cap

$208.25M

Revenue (TTM)

$0.00

Net Income (TTM)

-$415.07M

EPS (TTM)

-$29.16

P/E Ratio

-0.15

Dividend

$0.00

Beta (Volatility)

0.28 (Low)

Dividend

$0.00

Beta (Volatility)

0.28 (Low)

Price

$4.68

Volume

164,926

Open

$4.50

Price

$4.68

Volume

164,926

Open

$4.50

Previous Close

$4.66

Daily Range

$4.38 - $4.74

52-Week Range

$1.57 - $12.46

Estimated Earnings Date

Aug 4, 2026

Dividend

$0.00

Beta (Volatility)

0.28 (Low)

Price

$4.68

Volume

164,926

Open

$4.50

Previous Close

$4.66

Daily Range

$4.38 - $4.74

52-Week Range

$1.57 - $12.46

Estimated Earnings Date

Aug 4, 2026

NERV News

These 2 Neuroscience Stocks Have Tanked as Much as 33% Since September 1. Are They Buys?

Maxx ChatskoOct 5, 2019

Here's Why Minerva Neurosciences Fell Over 28% Today

Maxx ChatskoOct 1, 2019

Why Minerva Neurosciences Inc. Fell 31.1% in July

Brian FeroldiAug 7, 2017

Why Minerva Neurosciences Stock Is Soaring Today

George Budwell, PhDJun 1, 2017

NERV: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Minerva Neurosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Rémy Henri Luthringer, PhD

Website

www.minervaneurosciences.com

Headquarters

Burlington, MA 02451, US

NERV Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-31%

Return on Assets

-4%

Earnings Yield

-6.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$208.25M

Shares Outstanding

46.59M

Volume

164.93K

Avg. Volume

223.95K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$15.10M

EBITDA

-$293.42M

Operating Cash Flow

-$13.51B

Capital Expenditure

$0.00

Free Cash Flow

-$13.51B

Cash & ST Invst.

$82.30M

Total Debt

$64.96M

Minerva Neurosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$208.25M

N/A

Market Cap/Employee

$26.03M

N/A

Employees

N/A

Net Income

-$125.40M

-3241.5%

EBITDA

-$125.40M

-3242.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$78.16M

+352.1%

Total Debt

$64.96M

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$64.96M

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-4.41%

N/A

Return on Invested Capital

-31.13%

N/A

Free Cash Flow

-$5.43B

-104937.6%

Operating Cash Flow

-$5.43B

-104937.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RLYBRallybio Corporation

RLYBRallybio Corporation$15.93-0.25%

KLTOKlotho Neurosciences, Inc.

KLTOKlotho Neurosciences, Inc.$0.38-7.10%

NRSNNeuroSense Therapeutics Ltd.

NRSNNeuroSense Therapeutics Ltd.$0.79-1.94%

XCURExicure, Inc.

XCURExicure, Inc.$2.74+18.61%

ENLVEnlivex Therapeutics Ltd.

ENLVEnlivex Therapeutics Ltd.$0.62+0.21%

TAOXTAO Synergies Inc.

TAOXTAO Synergies Inc.$3.63-1.09%

CVKDCadrenal Therapeutics, Inc. Common Stock

CVKDCadrenal Therapeutics, Inc. Common Stock$3.18-9.14%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TET1 Energy Inc.

TET1 Energy Inc.$10.40+0.11%

JOBYJoby Aviation

JOBYJoby Aviation$9.86-0.01%

TSLATesla

TSLATesla$405.19+0.01%

CMCSAComcast

CMCSAComcast$22.28-0.01%

MRVLMarvell Technology

MRVLMarvell Technology$307.32-0.01%

Questions About NERV

What is the current price of Minerva Neurosciences?

Minerva Neurosciences is trading at $4.66 per share.

What is the 52-week range for Minerva Neurosciences?

Over the past 52 weeks, Minerva Neurosciences has traded between $1.57 and $12.46.

How much debt does Minerva Neurosciences have?

As of the most recent reporting period, Minerva Neurosciences reported total debt of $64.96M.

How much cash does Minerva Neurosciences have on hand?

Minerva Neurosciences reported $32.76M in cash and cash equivalents in its most recent financial results.

What is Minerva Neurosciences’s dividend yield?

Minerva Neurosciences does not currently have a dividend yield.

Minerva Neurosciences

Minerva Neurosciences Financials at a Glance

NERV News

Why Minerva Neurosciences Is Heading Higher Today

Here's Why Minerva Neurosciences Collapsed Today

Why Minerva Neurosciences Stock Is Cratering Today

These 2 Neuroscience Stocks Have Tanked as Much as 33% Since September 1. Are They Buys?

Here's Why Minerva Neurosciences Fell Over 28% Today

Why Minerva Neurosciences Inc. Fell 31.1% in July

Why Minerva Neurosciences Stock Is Soaring Today

NERV: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Minerva Neurosciences

NERV Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Minerva Neurosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NERV

What is the current price of Minerva Neurosciences?

What is the 52-week range for Minerva Neurosciences?

How much debt does Minerva Neurosciences have?

How much cash does Minerva Neurosciences have on hand?

What is Minerva Neurosciences’s dividend yield?

Premium Investing Services